Chargement en cours...
Systematic review of fondaparinux for heparin‐induced thrombocytopenia: When there are no randomized controlled trials
BACKGROUND: Fondaparinux is commonly used for treatment of heparin‐induced thrombocytopenia (HIT) despite lack of approval for this indication. High quality randomized controlled trials of this agent are unlikely to be forthcoming. OBJECTIVES: The objective of this systematic review is to update the...
Enregistré dans:
| Publié dans: | Res Pract Thromb Haemost |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6178656/ https://ncbi.nlm.nih.gov/pubmed/30349886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12145 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|